LiveStocks in Focus: BHEL, Coromandel International, Biocon, and Others
The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading higher by 476 points at 22,956 indicating that the domestic...
Category : Latest News
Stocks Under F&O Ban: National Aluminium, Manappuram Finance, and Others
Under the futures and options (F&O) segment, four stocks were banned from trade on Friday, 11 April, by the National Stock Exchange (NSE). The securities...
OpenAI Hits Back at Elon Musk with Countersuit, Alleging Harassment
OpenAI has countersued Elon Musk, accusing him of harassment and seeking a court order to block further legal action. Musk, who co-founded OpenAI in 2015...
China Hints at Rate Cuts to Offset Trump’s Tariffs
A Chinese state newspaper signalled the need for monetary easing as US trade tensions threaten economic growth, suggesting the central bank should cut interest rates...
Russia, US to Discuss Diplomatic Missions in Upcoming Talks
Russia and the US will hold talks in Istanbul on Thursday to discuss normalising diplomatic missions, led by Russian Ambassador Alexander Darchiev and US Deputy...
Audi Sets Up 6,500 EV Chargers in India, 75% Are Fast Chargers
Audi India announced on Thursday that it has set up over 6,500 EV charging points nationwide as part of Phase II of its ‘Charge My...
Xindus Raises $10 Million to Scale Cross-Border Logistics for SMEs
Gurugram-based cross-border logistics startup Xindus has secured $10 million (approximately Rs 83.5 crore) in a Series A funding round led by 3one4 Capital. The round...
JSW Energy Completes Acquisition of 4.7 GW Renewable Platform
JSW Energy Limited announced that it had successfully acquired a 4.7 GW renewable energy platform from O2 Power Pooling Pte. Ltd. for an enterprise value...
GIFT Nifty Surges as Donald Trump’s 90-Day Tariff Freeze Boosts Sentiment
Indian markets are predicted to open well on Friday, 11 April, with GIFT Nifty trends pointing to a healthy gain of 600 points, or 2.5%,...
Biocon Subsidiary Secures USFDA Approval
Biocon Biologics, a subsidiary of Biocon, reported on Thursday, 10 April, that the US Food and Drug Administration (FDA) had approved its antibody Jobevne. The...